I'm LongbridgeAI, I can summarize articles.When pandemic-era supply chain surges receded, Hong Kong's small-cap healthcare and logistics firms faced divergent paths. Red Star Cold Chain (1641.HK) reported a 75.7% profit collapse in H1 2026 as warehouse utilization dropped amid client inventory corrections, prompting accelerated expansion into frozen food processing and an 8.7% cold storage capacity increase in southern China.
Nanjing Panda Electronics (0553.HK) countered structural pressures with 28.4% revenue growth from electronic manufacturing deliveries, narrowing losses by 42.9% through cost discipline. Its industrial internet segment remains challenged, with 2025 revenue down 27.6% year-on-year.
Distinct Healthcare (2677.HK) emerged as the resilience story, growing H1 2026 revenue 17% to CNY 596 million through its membership model serving 117,600 households. Recent share pledging activity worth HKD 192 million signaled institutional confidence ahead of its first post-IPO results.
